Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children’s Oncology Group Study AALL1131 - Concepedia

Concepedia

Publication | Open Access

Impact of Intrathecal Triple Therapy Versus Intrathecal Methotrexate on Disease-Free Survival for High-Risk B-Lymphoblastic Leukemia: Children’s Oncology Group Study AALL1131

DOI Full Paper Access

77

Citations

32

References

2020

Year

Wanda L. Salzer, Michael J. Burke, Meenakshi Devidas, Yunfeng Dai, Kristina K. Hardy, John A. Kairalla, Lia Gore, Joanne M. Hilden, Eric Larsen, Karen R. Rabin,

Journal of Clinical Oncology

Abstract

Postinduction CNS prophylaxis with ITT did not improve 5-year DFS for children with HR B-ALL. The standard of care for CNS prophylaxis for children with B-ALL and no overt CNS involvement remains IT MTX.

References

	Year	Citations

Page 1